Entera Bio (ENTX) Times Interest Earned (2021 - 2026)
Entera Bio (ENTX) posted quarterly Times Interest Earned of -$49.15 for Q1 2026, down 7.4% year-on-year from -$53.08 in Q1 2025, and down 76.88% on a QoQ basis from -$27.79 in Q4 2025.
Entera Bio (ENTX) Times Interest Earned (2021 - 2026) Analysis & Trends
Entera Bio (ENTX) has reported Times Interest Earned for 6 consecutive years, with -$49.15 the latest figure, recorded in Q1 2026.
- Quarterly Times Interest Earned fell 7.4% year-over-year to -$49.15 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$36.43 (down 58.01% YoY) and the FY2025 annual result came in at -$0.5, down 9.34% from the prior year.
- Times Interest Earned eased to -$49.15 in Q1 2026 per ENTX's latest filing, from -$27.79 in the prior quarter.
- Over the last five years, Times Interest Earned for ENTX reached as high as -$0.1 in Q4 2023 and fell as low as -$94.41 in Q3 2024.
- A 5-year average of -$30.46 and a median of -$22.57 in 2025 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2024 — Times Interest Earned sank 19883.37% — and 2025, when it surged 73.52%.
- Year by year, Times Interest Earned stood at -$0.17 in 2022, then jumped by 42.02% to -$0.1 in 2023, then plunged by 19883.37% to -$20.15 in 2024, then tumbled by 37.93% to -$27.79 in 2025, then sank by 76.88% to -$49.15 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$49.15, -$27.79, and -$25.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -0.38 |
| 10 | Entera Bio | 186.78 Mn | 182.64 Mn | - | -49.15 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49.15 |
| Dec 31, 2025 | -27.79 |
| Sep 30, 2025 | -25.00 |
| Jun 30, 2025 | -84.38 |
| Mar 31, 2025 | -45.77 |
| Dec 31, 2024 | -20.15 |
| Sep 30, 2024 | -94.41 |
| Jun 30, 2024 | -9.36 |
| Dec 31, 2023 | -0.10 |
| Sep 30, 2023 | -5.00 |
| Jun 30, 2023 | -4.30 |
| Dec 31, 2022 | -0.17 |
| Dec 31, 2021 | -0.27 |